Market News

This chart from investment advisory firm, Virtue Capital Partners Ltd, provides an up-to-date snapshot of how the US and the UK compare in terms of their respective investment in anti-COVID 19 vaccines and drugs, providing useful data such as number of...

This milestone secures future production of CombiGene's CG01 drug candidate to treat drug-resistant focal epilepsy.

Company working to ensure broad global access to COVID-19 vaccine candidate, following approval from regulators.

One of India's fastest growing CDMOs goes "beyond the norm" to reinvent itself as a new generation global CDMO.

The transaction will enable Sanofi to expand and accelerate development of BTK inhibitors across multiple indications, including MS and other central nervous system diseases.

The instrument also tests ethanol and isopropanol concentrations to confirm product efficacy.

The free webinar investigates online training and how it can essentially optimize the tablet manufacturing process.

Atomwise technology removes the barriers of physical screening that have limited the success of traditional methods for small molecule drug discovery.

Details of new CPHI South East Asia Online Business Matchmaking Platform to be announced shortly.

The company is also scaling up its manufacturing capability with its partners — Lonza, Catalent and Rovi — should the vaccine get the green light.

The company has reserved one fill/finish line for the next 18 months to guarantee the supply of vaccines required to fight COVID-19 in the UK.

Customers in the region will have the opportunity to conduct laboratory-scale compression and coating trials, using automated coating equipment.

New mid-scale microbial facility will support Servier with API for acute lymphoblastic leukemia therapies.

The company expects to manufacture the clinical-stage gene therapy product in its commercial-scale GMP manufacturing facilities.

Discussions relate to vaccine candidate using Sanofi’s recombinant protein-based technology combined with GSK’s pandemic adjuvant system.

The companies are set to manufacture globally up to 100 million doses by the end of 2020 and approximately 1.3 billion doses by the end of 2021.

The transaction will enable the CDMO to offer plasmid production and end-to-end cell and gene therapy services.

The European Medicines Agency's human medicines committee (CHMP) has recommended the suspension of European marketing authorizations of generic medicines tested by Panexcell Clinical Laboratories at its site in Mumbai, India, citing irregularities in h...

The company will adapt its digital platform to digitize any COVID-19 antibody rapid test assay and embed this within an app available on smartphones and tablets.

The event organizers are working on preparing bespoke digital product offerings to help the market continue to meet, do business and exchange ideas later this year.

The data generated through the partnership will help biopharma companies to develop robust manufacturing processes and minimize challenges during scale-up and commercialization.

Acryl-EZE formulations provide significant time savings and targeted drug delivery.

Watson-Marlow's new Certa Plus sinusoidal pump provides a sustainable solution for shear sensitive, viscous pharmaceutical products.

Sterile transfer solutions without compromising operational efficiency.

Junshi Biosciences cites Lonza’s GS Xceed gene expression system as a critical enabler for the program.

The company is also involved in projects that aim to enable population-level screening for the current coronavirus.

Further milestone paves the way for production of novel gene therapy drug candidate designed to treat drug-resistant focal epilepsy.

The center will host a new BioReliance End-to-End Solutions GMP manufacturing facility offering CDMO services to customers in China and Asia-Pacific.

The agreement is aimed at helping to reduce essential drug shortages in the US

The company began scaling up manufacturing of REGN-COV2 at business risk earlier this year to ensure the immediate availability of the product if clinical trials prove successful.

The CRO will undertake this clinical trial at multiple sites worldwide, starting at the AZ Sint Maarten hospital in Mechelen, Belgium.

The transaction will more than double Croda’s R&D capability in drug delivery.

Following on from the success of the inaugural iPitch launch in 2019, iNova Pharmaceuticals is delighted to announce the launch of a new round of iPitch challenges for 2020.

The 10-day event will feature an interactive digital marketplace for sourcing products and services, enhanced matchmaking for connecting with new and existing partners, and world-renowned speakers.

SeaGel offers drug and dietary supplement manufacturers an animal-free and sustainable alternative to traditional soft capsules.

The global outsourcing solutions provider is also set to expand its biotech capabilities in Europe.

The prefilled pen supports more convenient self-administration for patients with chronic type 2 inflammatory diseases.

Luxembourg, 28 May 2020 -- CordenPharma, a full-service Contract Development & Manufacturing Organization (CDMO) for the supply of APIs, Drug Products & Pharmaceutical Packaging, announces the signing of an amendment to their existing manufacturing agr...

Pionyr's "promising, novel biology" could represent a major increase in Gileads's cancer pipeline.

As Bill Gates had correctly predicted in 2015, the greatest threat to humanity was not nuclear missiles, but microbes.

Novel platform initially focussed on high-resolution industrial-scale processing of therapeutic mRNA.

Stevanato Group, SCHOTT, and Gerresheimer confirm their readiness to support future COVID-19 vaccine with pharmaceutical containers.

The French pharma company will also invest EUR 120 million to create a new research center at Marcy-l'Etoile dedicated to vaccines

The cost-effective capsules incorporate anti-tampering measures to ensure they comply with blinding regulations.

An aging population and high incidence of NCDs is continuing to drive the demand for healthcare in Thailand, where 20% of the population is aged 65 or over. Our CPHI South East Asia webinar examines the challenges associated with dosage form design for...

Webinar will help manufacturers to harness the advantages of using real-time analytics to enhance performance and reduce waste.

The collaboration will significantly increase the UK’s capacity to manufacture viral vectors vaccines as part of a national effort in response to COVID-19.

Optimizing the dosage form's efficiency reduces the amount of drug required in each patch.

The collaboration with CGT Catapult will enable Achilles to increase its GMP manufacturing capacity to supply clinical trials of its novel T cell therapy products.

The CDMO produce drug substance at large scale for commercial manufacturing with the first 2 years valued at approximately $480 million.

The rush to find effective vaccines against the coronavirus is only one part of the story. How is the pharmaceutical industry addressing the difficult issue of ensuring there will be enough manufacturing capacity to roll them out on a global scale?

Global Pharma Insights speaks to Stefan Schmidinger, Partner at Kemiex AG, on how its trade platform is bringing efficiency to a fragmented and regulated market and how traders of APIs are slowly embracing the digital revolution

The Boulder, Colorado, USA facility will increase global capacity and extend manufacturing scale.

The company will provide CDMO capabilities, capacities, and expertise to support the US government’s Warp Speed Program to pave the way for innovators to advance COVID-19 programs.

US TEC will support biopharma drug development throughout the lifecycle, helping them overcome the challenges of the container-closure system.

Vaxxas announces Merck (known as MSD outside the US and Canada) milestone and Harro Höfliger manufacturing alliance.

The licence will allow the company to perform EU clinical release for its European customers and drug developers.

SeraNovo enters into a second license agreement with Carna Biosciences for development of oral formulation of Carna’s kinase inhibitor.

Researchers endorse a switch from the current first-filer system in the US to a system that instead rewards the first successful challenger.

Reducing dependence on China would increase production costs for generic drug makers, analysts say

The invention could pave the way for treatments to cure Parkinson's and Alzheimer's disease.

AbCellera, will use its antibody drug discovery platform to identify antibodies against up to nine targets.

The novel method paves the way towards the mass production of affordable therapeutic drugs that are made with recyclable materials.

ChargePoint Technology's Chief Commercial Officer says "yes" it can.

Although the industry might be 30% along its sustainability journey, greater interoperability is needed from materials to devices.

CDMO is contracted to produce multiple clinical batches from German facility

Voluntary licensing deals allow firms to distribute drug recently granted FDA EUA to treat patients with COVID-19 in 127 countries

CDMO says it has made "notable changes" to its supply chain processes to ensure continuing supply of medicines during COVID-19 pandemic

New application study describes the separation and characterisation of adeno associated virus serotypes by AF4.

Company's manufacturing methods and processes reviewed by an independent third-party auditor to ensure the products have the highest-quality ingredients possible.

Movement towards healthy lifestyles and preventative supplements the lasting behavioural change post COVID-19.

Collaborations focus on gene therapies for serious eye and muscle diseases using Dyno’s CapsidMap artificial intelligence platform to design AAV vectors.

Biotech in discussions with pharmaceutical and chemical manufacturers on how to broaden supply of antiviral that last week received an emergency use authorization for treatment of COVID-19 from the FDA

The contract packaging company has plans to install new equipment for the company’s blister and bottle lines, vial labelling, stability chambers and cold storage capacity.

Using this critical antibody reagent at the preclinical stage of development will minimize the need to revalidate assays with different reagents at the clinical development stage.

By bringing tabletting knowledge to home offices and desk tops, the company encourages its customer to stay safe and stay skilled.

The new business unit will focus on existing automated biomanufacturing products, as well as launching new technologies.

The system has the potential to revolutionise the turnaround time for the assessment of suspected UTIs and reduce the use of antibiotics.

The addition of various laboratory and bioprocessing technologies will support customers to develop biotech medicines and vaccines.

Human plasma-derived product will be developed and manufactured utilizing Kamada’s proprietary IgG platform technology

The CPO has immediate plans to expand its automated packaging capabilities, including for injectable products.

The acquisition will strengthen Wasdell’s capabilities and product offerings, including 100% recyclable and biodegradable options, in the medical device sector.

Syntegon's new coater series can handle tablets with highly potent active ingredients.

CDMO to supply drug substance manufacturing services and reserve capacity for possible commercial production next year

The acquisition will enhance senior-level expertise, which will support clients from Diamond’s regulatory affairs business in specialist areas such as gene and cell therapies.

Submit your entry before 1 July 2020!

Date alteration taken at the request of exhibitors to ensure the international character of China’s largest pharma exhibition.

Decisions by individual European countries to ensure medicines availability during the COVID-19 pandemic are complicating international supply chains, industry association says

The 8Shot DPI is capable of delivering high doses of drug to the lungs.

Syntegon to showcase flexible solutions for small and microbatches, new developments for liquid filling and assembly, as well as AI-enhanced product safety.

New solutions will provide critical transparency to the life sciences supply chain, mobilizing companies to rapidly react to unforeseen disruptions and ensure medicine supply.

Importing countries’ embassies are being asked to submit detailed requests for the key medicines amid COVID-19 pandemic

Companies to combine innovative technologies to develop an adjuvanted coronavirus vaccine 

The CultureOne separator system uses product-contact parts that are replaceable and made from recyclable material.

Zynamite is an all-natural evidence-based nootropic and sports performance ingredient, supported by clinical studies.

Despite current travel restrictions, the machine manufacturer manages to perform factory acceptance tests (FATs) via a live stream at its manufacturing facility.

Independent Data Monitoring Committee (IDMC) recommends unblind Phase III trial of Tagrisso 2 years ahead of schedule.

Blockchain technology could prove to be the missing link for global healthcare supply chains exposed by the COVID-19 pandemic in building resilience and galvanizing efficiency, transparency and authenticity, according to market research firm, GlobalDat...

The biotech pioneer is one of the first companies to develop corporate partnerships in this application of artificial intelligence (AI) for drug discovery.

The head of the leading German pharmaceutical industry organization says German firms are working top-speed to find coronavirus medications.

The FectoVIR-AAV transfection reagent achieves large-scale transient transfection resulting in up to a 10-fold increase in AAV functional viral titer yields in suspension cell systems.

Move comes 24 hours after US President warns of "retaliation" if export ban was not lifted

Symphogen becomes the antibody center of excellence within Servier.

The platform enables collaboration between pharmaceutical institutions, healthcare and academic researchers to generate valuable insights and advance medical research.

Our content has now moved to our new Global Pharma Insights website, providing the very latest news and information covering all aspects of the pharmaceutical supply chain. Please click the link below to access this article.

The Ritedose Corporation, a contract development and manufacturing organisation (CDMO) with a focus on inhalation and ophthalmic products, has partnered with ChargePoint Technology to ensure the sterility of its drug substance mixing process.

Study data support blood test's ability to detect 50 types of cancer and identify where in the body the cancer is located.

Specialist cleanroom microbiology solutions company offers the new SAS Super Pinocchio CR compressed air sampling device.

Joint venture between Spinview and VR Media Technology creates device that provides accurate and fast detection of infectious people with far greater clarity than any single parameter test available today.

The European Medicines Agency (EMA) said Monday it will only issue electronically signed and authenticated certificates for human and veterinary medicines in place of printed ones so it can continue to provide the documents during the COVID-19 pandemic...

Indian contract development and manufacturing organisation, Suven Pharmaceuticals, has warned it cannot export finished products due to a shortage of raw materials following the country’s recent lockdown to fight the COVID-19 pandemic.

Together, the companies will provide APAC markets with a cost-effective alternative to the largest-selling blockbuster medicine worldwide.

Collaboration with MedPharm delivers data profiling new XF‐platform drug formulations as potential treatments for dermal and ocular infections.

The Contract Development and Manufacturing Organization (CDMO) and technology provider will use its CHO.RiGHT expression platform for high-titer cell line development.

The TheraPEAK SfAAV Medium is specifically designed to support the development of safe, scalable, gene therapies.

The new formulation offers patients in Europe an alternative route of administration of the only fixed antiemetic combination targeting two distinct CINV pathways in a single dose.

Fierce competition in the low cost, high volume API sector is forcing suppliers to invest in capacity and accelerate throughout. 

Despite consolidation, competition between manufacturers is fierce and the generic drug market continues to grow.

Fujifilm Diosynth Biotechnologies will triple microbial production capacity at its UK Teesside facility after joint owner Fujifilm Corporation pledged to invest 9 billion yen (USD83 million) in the biologics focused CDMO.

Cell and gene focused CDMO Oxford Biomedica (OXB) has signed a licence and clinical supply agreement which could be worth up to USD227 million with Juno Therapeutics, the firms announced Wednesday.